XENT
Intersect ENT, Inc
XENT
XENT
Delisted
XENT was delisted on the 12th of May, 2022.
160 hedge funds and large institutions have $1.03B invested in Intersect ENT, Inc in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 67 increasing their positions, 50 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
42% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 26
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
160
Holding in Top 10
1
Calls
$6.19M
Puts
$3.41M
Top Buyers
| 1 | +$30.1M | |
| 2 | +$17.3M | |
| 3 | +$14.9M | |
| 4 |
BlackRock
New York
|
+$13.9M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$13M |
Top Sellers
| 1 | -$20.1M | |
| 2 | -$19.6M | |
| 3 | -$13.6M | |
| 4 |
Millennium Management
New York
|
-$8.89M |
| 5 |
Neuberger Berman Group
New York
|
-$8.45M |